128 related articles for article (PubMed ID: 22447788)
1. A vaccine against myxomatosis and RHD: a step forward for rabbit health.
Meredith A
Vet Rec; 2012 Mar; 170(12):307-8. PubMed ID: 22447788
[No Abstract] [Full Text] [Related]
2. Novel bivalent vectored vaccine for control of myxomatosis and rabbit haemorrhagic disease.
Spibey N; McCabe VJ; Greenwood NM; Jack SC; Sutton D; van der Waart L
Vet Rec; 2012 Mar; 170(12):309. PubMed ID: 22266680
[TBL] [Abstract][Full Text] [Related]
3. Horizontal transmissible protection against myxomatosis and rabbit hemorrhagic disease by using a recombinant myxoma virus.
Bárcena J; Morales M; Vázquez B; Boga JA; Parra F; Lucientes J; Pagès-Manté A; Sánchez-Vizcaíno JM; Blasco R; Torres JM
J Virol; 2000 Feb; 74(3):1114-23. PubMed ID: 10627521
[TBL] [Abstract][Full Text] [Related]
4. A case of low success of blind vaccination campaigns against myxomatosis and rabbit haemorrhagic disease on survival of adult European wild rabbits.
Rouco C; Moreno S; Santoro S
Prev Vet Med; 2016 Oct; 133():108-113. PubMed ID: 27663647
[TBL] [Abstract][Full Text] [Related]
5. First field trial of a transmissible recombinant vaccine against myxomatosis and rabbit hemorrhagic disease.
Torres JM; Sánchez C; Ramírez MA; Morales M; Bárcena J; Ferrer J; Espuña E; Pagès-Manté A; Sánchez-Vizcaíno JM
Vaccine; 2001 Aug; 19(31):4536-43. PubMed ID: 11483281
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous lesions in pet rabbits following subcutaneous administration of a novel bivalent vaccine against myxomatosis and rabbit haemorrhagic disease.
Selleri P; Di Girolamo N; Vögtlin A; Fileccia I; Hoop R; Bongiovanni L
Vet Dermatol; 2014 Dec; 25(6):563-6, e100. PubMed ID: 25227274
[TBL] [Abstract][Full Text] [Related]
7. Possible interaction between myxomatosis and calicivirosis related to rabbit haemorrhagic disease affecting the European rabbit.
Marchandeau S; Bertagnoli S; Peralta B; Boucraut-Baralon C; Letty J; Reitz F
Vet Rec; 2004 Nov; 155(19):589-92. PubMed ID: 15573951
[TBL] [Abstract][Full Text] [Related]
8. Effects of vaccination against viral haemorrhagic disease and myxomatosis on long-term mortality rates of European wild rabbits.
Calvete C; Estrada R; Lucientes J; Osacar JJ; Villafuerte R
Vet Rec; 2004 Sep; 155(13):388-92. PubMed ID: 15499810
[TBL] [Abstract][Full Text] [Related]
9. Protection against myxomatosis and rabbit viral hemorrhagic disease with recombinant myxoma viruses expressing rabbit hemorrhagic disease virus capsid protein.
Bertagnoli S; Gelfi J; Le Gall G; Boilletot E; Vautherot JF; Rasschaert D; Laurent S; Petit F; Boucraut-Baralon C; Milon A
J Virol; 1996 Aug; 70(8):5061-6. PubMed ID: 8764013
[TBL] [Abstract][Full Text] [Related]
10. Control of viral haemorrhagic disease of rabbits in Poland.
Górski J; Mizak B; Chrobocińska M
Rev Sci Tech; 1994 Sep; 13(3):881-91. PubMed ID: 7949360
[TBL] [Abstract][Full Text] [Related]
11. [Recombinant vaccine against rabbit hemorrhagic disease virus].
Vautherot JF; Laurent S; Le Gall G; Morisse JP; Rasschaert D
Vet Res; 1995; 26(3):206-7. PubMed ID: 7795676
[No Abstract] [Full Text] [Related]
12. Coccidian and nematode infections influence prevalence of antibody to myxoma and rabbit hemorrhagic disease viruses in European rabbits.
Bertó-Moran A; Pacios I; Serrano E; Moreno S; Rouco C
J Wildl Dis; 2013 Jan; 49(1):10-7. PubMed ID: 23307367
[TBL] [Abstract][Full Text] [Related]
13. Vaccine breaks: Outbreaks of myxomatosis on Spanish commercial rabbit farms.
Dalton KP; Nicieza I; de Llano D; Gullón J; Inza M; Petralanda M; Arroita Z; Parra F
Vet Microbiol; 2015 Aug; 178(3-4):208-16. PubMed ID: 26009303
[TBL] [Abstract][Full Text] [Related]
14. Safety evaluation of a recombinant myxoma-RHDV virus inducing horizontal transmissible protection against myxomatosis and rabbit haemorrhagic disease.
Torres JM; Ramírez MA; Morales M; Bárcena J; Vázquez B; Espuña E; Pagès-Manté A; Sánchez-Vizcaíno JM
Vaccine; 2000 Sep; 19(2-3):174-82. PubMed ID: 10930670
[TBL] [Abstract][Full Text] [Related]
15. Vaccination strategies against myxomavirus infections: are we really doing the best?
Marlier D
Tijdschr Diergeneeskd; 2010 Mar; 135(5):194-8. PubMed ID: 20334023
[TBL] [Abstract][Full Text] [Related]
16. Impact of viral hemorrhagic disease on a wild population of European rabbits in France.
Marchandeau S; Chantal J; Portejoie Y; Barraud S; Chaval Y
J Wildl Dis; 1998 Jul; 34(3):429-35. PubMed ID: 9706551
[TBL] [Abstract][Full Text] [Related]
17. Vaccination of free-living juvenile wild rabbits (Oryctolagus cuniculus) against myxomatosis improved their survival.
Guitton JS; Devillard S; Guénézan M; Fouchet D; Pontier D; Marchandeau S
Prev Vet Med; 2008 Apr; 84(1-2):1-10. PubMed ID: 18045714
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of SG33 and Borghi vaccines used against myxomatosis.
Cavadini P; Botti G; Barbieri I; Lavazza A; Capucci L
Vaccine; 2010 Jul; 28(33):5414-20. PubMed ID: 20598407
[TBL] [Abstract][Full Text] [Related]
19. Myxomatosis vaccine.
Lawton MP
Vet Rec; 1992 May; 130(18):407-8. PubMed ID: 1609472
[No Abstract] [Full Text] [Related]
20. A comparison of the immunogenic efficacy of a bivalent vaccine against pasteurellosis and rabbit haemorrhagic disease with that of three monovalent vaccines against rabbit haemorrhagic disease.
Peshev R; Christova L
Vet Res Commun; 2003 Oct; 27(7):591-4. PubMed ID: 14609270
[No Abstract] [Full Text] [Related]
[Next] [New Search]
